This biotech’s stock rockets on oral obesity drug partnership with Wegovy parent

1 month ago 5
ARTICLE AD BOX
Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments.
Read Entire Article
  1. Homepage
  2. Finance
  3. This biotech’s stock rockets on oral obesity drug partnership with Wegovy parent

Related

Sleeping beauty bitcoin wallets wake up after 14 years to the tune of $2 billion

Sleeping beauty bitcoin wallets wake up after 14 years to th...

11 minutes ago 0
This Is Why Tesla’s Robotaxi Launch Needed Human Babysitters

This Is Why Tesla’s Robotaxi Launch Needed Human Babysitters...

16 minutes ago 0
Indian regulator locks U.S. trading firm out of its stock market, accusing it of ‘index manipulation’ and ‘unlawful gains’

Indian regulator locks U.S. trading firm out of its stock ma...

2 hours ago 0

Trending

1. celebrity cruises
2. melania trump
3. americas birthday
4. current mortgage rates
5. aldis hours
6. charlize theron old guard
7. jamie smith
8. cape cod
9. espncricinfo
10. milwaukee weather

Popular

Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

4 months ago 210
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

4 months ago 173
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

4 months ago 173
Google's Magic Editor will watermark its AI-tweaked photos

Google's Magic Editor will watermark its AI-tweaked photos

4 months ago 157
Metal Gear Solid Delta: Snake Eater release date leaks on the PlayStation Store

Metal Gear Solid Delta: Snake Eater release date leaks on th...

4 months ago 153
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved